Similarly, the combination of digitoxin and sorafenib has been reported to suppress p-ERK, hypoxia inducible factor (HIF)-1α, HIF-2α, and VEGF expression, contributing to apoptosis in cancer cells [89]. This evidence concerns the gene EPAS1 and cancer.